Mushroom and Silymarin Supplementation to Reduce Alzheimer’s Disease Progression: A Research Protocol
Bibliographic record
Abstract
As life expectancy continues to rise, the incidence of diseases like Alzheimer’s disease (AD) increases. Curative fronts remain far from satisfactory. Interestingly, the gut microbiome may modulate brain functions. Shiitake mushroom β-(1,3)/(1,6)-glucans are dietary fibres that attenuate pro-inflammatory signalling, and silymarin is a neuroprotective agent, but their effect on AD progression remains elusive. This research protocol aims to examine the effects of shiitake mushroom β-glucan and silymarin supplementation in early-stage AD to reduce progression. A literature search was conducted to formulate this protocol. The potential of this nutraceutical supplementation against AD progression will be tested within mice models. Experimental groups will be fed with mushroom β-glucans and/or silymarin supplementation. Cognitive testing will involve novel object exploration time and Y-maze tests. Furthermore, brain and intestine tissues will be analyzed ex vivo to understand the nutraceutical supplement’s effects on the gut-brain axis in AD. It is anticipated that results demonstrate a synergistic effect of mushroom β-glucans and silymarin to reduce AD progression. This proposed nutraceutical supplement shows promise in reducing AD progression for individuals with early-stage AD. It also provides the foundation for future research on accessible interventions for cognitive impairment.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.005 | 0.004 |
| Meta-epidemiology (narrow) | 0.002 | 0.001 |
| Meta-epidemiology (broad) | 0.004 | 0.004 |
| Bibliometrics | 0.002 | 0.001 |
| Science and technology studies | 0.002 | 0.001 |
| Scholarly communication | 0.002 | 0.001 |
| Open science | 0.003 | 0.002 |
| Research integrity | 0.005 | 0.004 |
| Insufficient payload (model declined to judge) | 0.038 | 0.006 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".